Canada bought into COVAX with $440 million, half of which secured doses for Canadians, and the other half to help buy doses for 92 nations who need help to buy vaccines.» read more
The COVID-19 pandemic has resulted in border closures and an increased desire to localize production and use supply chains that are close to home» read more
Glass Lewis, which also came out against the initial offer, says efforts by Dorel’s board to win support have failed to convince the company’s largest shareholders.» read more